Jobs / United States / Pfizer INC
Senior Strategic Healthcare Partner / Partenaire Stratégique Principal en Santé - Western Canada
Pfizer INC · 🇺🇸 3 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Pfizer INC
The US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 9 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Pfizer INC →
About the role
Posting closing date: October 20, 2026 Date de fin d’affichage : Le 20 octobre 2026 Status: Permanent, Full Time Statut : Permanent, temps plein Location/Lieu : Western Canada (Français à suivre) SENIOR STRATEGIC HEALTHCARE PARTNER: Global Hospital & Biosimilars ROLE PURPOSE: The Senior Strategic Healthcare Partner (SSHP) is a strategic, non-demand-generating role that strengthens partnerships across the western Canadian healthcare ecosystem in gastroenterology, rheumatology, and hospital/institutional care. With a distinct, non-promotional mandate, the SSHP builds trusted relationships with healthcare professionals, institutions, hospital leaders, and community stakeholders to identify care gaps and co-create solutions that improve access, timeliness, care pathways, patient flow, system capacity, and sustainability. The SSHP collaborates compliantly across functions, including field and Head Office partners, while preserving its non-promotional mandate. As a strategic bridge between Pfizer and healthcare stakeholders, the SSHP translates system insights and evolving healthcare and pharmacy practices into quality-improvement initiatives aligned with Global Hospital & Biosimilars priorities. The role requires a creative, entrepreneurial, customer-centric, proactive leader who can navigate complex healthcare environments, build trusted partnerships, and mobilize stakeholders around innovative solutions that improve access and support a more efficient, sustainable healthcare system. RESPONSIBILITIES: Gastroenterology (IBD) / Rheumatology • Partner with community and academic gastroenterology and rheumatology stakeholders to understand patient journeys, care pathways, system readiness, unmet patient and healthcare-system needs, and barriers to timely, appropriate care. • Co-create scalable workflow and care-pathway solutions that improve patient flow, practice capacity, and care delivery. • Generate system insights that support efficient, sustainable, patient-centred care models. Hospitals & Institutions • Serve as a strategic partner to hospitals and institutions, focusing on oncology biosimilars, supportive care, and anticoagulation. • Understand institutional care pathways, operational challenges, and system readiness. • Collaborate with institutional stakeholders to improve infusion capacity, patient flow, continuity of care, and, where appropriate, institution-led biosimilar transitions. • Co-create quality-improvement initiatives that optimize capacity, resources, and sustainability. • Build trusted relationships with pharmacy directors, clinic managers, medical leaders, and other key stakeholders. Strategic Partnerships & Healthcare-System Innovation • Explore innovative partnership models, tools, workflows, and care-enablement approaches addressing identified patient and system needs. • Support standardized processes and frameworks aligned with Canadian evidence-based guidelines, expert opinion, and stakeholder needs. • Lead or support compliant Strategic Healthcare Enhancement Projects and quality-improvement initiatives with appropriate governance and defined responsibilities. • Generate and communicate healthcare-system insights to inform organizational understanding and strategic planning. • Support sharing and scaling relevant quality-improvement learnings across healthcare settings. Cross-Functional Collaboration & Compliance • Collaborate compliantly with cross-functional colleagues, with clear roles and responsibilities within each function’s scope. • Maintain the SSHP’s distinct, non-promotional, non-demand-generating mandate in all activities and engagements. • Represent Pfizer at relevant conferences, meetings, and events as a credible strategic partner. • Conduct all activities accordi